VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

E protein from Dengue Virus 2

Gene Name E protein from Dengue Virus 2
VO ID VO_0011311
NCBI Protein GI 202078796
3D structure: PDB ID 1OAN
Other Database IDs CDD:279241
CDD:213392
CDD:213897
Taxonomy ID 11060
Gene Strand (Orientation) ?
Protein Name envelope protein
Protein pI 7.67
Protein Weight 50568.28
Protein Length 559
Protein Note Flavivirus glycoprotein, central and dimerisation domains; pfam00869
Protein Sequence
>ACH96447.1 envelope protein, partial [Dengue virus 2]
MRCIGISNRDFVEGVSGGSWVDIVLEHGSCVTTMAKNKPTLDFELIKTEAKHPATLRKYCIEAKLTNTTT
ASRCPTQGEPSLNEEQDKRFVCKHSMVDRGWGNGCGLFGKGGIVTCAMFTCKKNMEGKIVQPENLEYTIV
ITPHSGEENAVGNDTGKHGKEIKVTPQSSITEAELTGYGTVTMECSPRTGLDFNEMVLLQMENKAWLVHR
QWFLDLPLPWLPGADTQGSNWIQKETLVTFKNPHAKKQDVVVLGSQEGAMHTALTGATEIQMSSGNLLFT
GHLKCRLRMDKLQLKGMSYSMCTGKFKVVKEIAETQHGTIVVRVQYEGDGSPCKIPFEIMDLEKRHVLGR
LITVNPIVTEKDSPVNIEAEPPFGDSYIIIGVEPGQLKLSWFKKGSSIGQMFETTMRGAKRMAILGDTAW
DFGSLGGVFTSIGKALHQVFGAIYGAAFSGVSWTMKILIGVVITWIGMNSRSTSLSVSLVLVGVVTLYLG
VMVQA

Molecule Role Protective antigen
Molecule Role Annotation A recombinant baculovirus encoding a dengue (DEN)-2 virus envelope glycoprotein truncated of 102 amino acids (aa) at its C-terminus (D2EA102) was constructed. Both intracellular and extracellular D2EA102 induced neutralizing antibodies in mice and were thus immunogenic. Sixty eight percent (P < 0.001) of mice vaccinated with 5 gg of extracellular D2EA102 protein were protected against lethal challenge (Delenda et al., 1994).
Related Vaccines(s) CAdVax-Den12/Den34 , Dengue Subunit E Protein Vaccine , Dengue virus DNA vaccine 1040D2MEL encoding dengue-2 prM-E-LAMP chimeric protein , Dengue virus DNA vaccine p1012D2ME encoding prM and E from DEN 2 New Guinea C strain , Dengue virus DNA vaccine pE1D2 encoding E from Dengue Virus 2 strain New Guinea C , Dengue virus DNA vaccine sA encoding prM and E from Dengue Virus 4 , Dengue virus DNA vaccine sABC encoding prM and E , Dengue virus DNA vaccine sC encoding prM and E , Dengvaxia , rMV-TDV , TAK-003 , V180 - Aluminum Hydroxide Alhydrogel™ Adjuvant , V180 - ISCOMATRIX™ adjuvant , V180 - unadjuvanted
References